CasInvent Pharma
PrivateLast Round
Series A
Jul 2, 2025
Est. Valuation
$9M
Total Funding Raised
$7.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CasInvent Pharma is a biotechnology company that develops selective small molecule inhibitors of casein kinase 1 (CK1) for the treatment of resistant tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CasInvent Pharma Comparables
Compare CasInvent Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Edgewood Oncology | 81% | |
| KyDo Therapeutics | 78% | |
| Pin Therapeutics | 71% |
CasInvent Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 2, 2025 | ||||
| VC Round | Jul 2, 2025 | ||||
| Grant | Oct 1, 2024 | ||||
| Seed | May 28, 2024 | ||||
| Early Funding | Jan 30, 2024 | ||||
Seed | Sep 13, 2022 |
Key People
Founding team and executive leadership
CasInvent Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Garage Angels | Seed |
| i&i Prague | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 252% MoM, from 450 to 1.6K.
- May 15, 2026
Monthly visitors increased 291% MoM, from 107 to 418.
CasInvent Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CasInvent Pharma's valuation, stock price, and market status.
Is CasInvent Pharma a public or private company?
CasInvent Pharma is a private company.
What is the current stock price of CasInvent Pharma?
CasInvent Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is CasInvent Pharma worth (valuation)?
Valuation information for CasInvent Pharma is not publicly available.
Can I buy CasInvent Pharma stock?
CasInvent Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CasInvent Pharma's last funding round?
CasInvent Pharma's most recent funding round was Series A on July 2, 2025.
Who are the main investors in CasInvent Pharma?
Key investors in CasInvent Pharma include i&i Prague.
Will CasInvent Pharma IPO soon?
No public IPO plans have been announced for CasInvent Pharma.
How can I track CasInvent Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CasInvent Pharma's secondary market activity and sign up for updates.